Tuesday, March 17, 2026

North Korea Claims Defense and Economic Supremacy Under Kim Jong Un

North Korea claims to be a powerful nation, emphasizing achievements in economy, military, and culture on Kim Il Sung's death anniversary.

K-pop Kings! SEVENTEEN’s New Album Soars Past 2 Million Sales in a Single Day

SEVENTEEN's mini album recorded sales of 2,494,180 copies sold on its release day, securing the top spot on the daily album chart.

EMPTY RHETORIC: Seoul And Washington Reaffirm A ‘Dead’ Policy. Why Are They Whispering When North Korea Is Yelling?

The U.S. and South Korea reaffirm commitment to North Korea's denuclearization, avoiding recognition of its nuclear status amid rising tensions.

Tag: drug

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

Huons BioPharma’s Botulinum Toxin HUTOX Set to Transform the Chinese Market

Huons BioPharma partners with iMaker Technology to supply botulinum toxin, aiming for a strong market presence in China.

New Diabetes Treatment: Chong Kun Dang’s Dubiempol Sustained Release Tablet Approved for Type 2 Diabetes in Korea

Chong Kun Dang's type 2 diabetes treatment, Dubiempol, gains approval, offering a new option for patients with uncontrolled blood sugar.

Inventage Lab Secures 985 Billion KRW: What This Means for Long-Lasting Injection Solutions

Inventage Lab secures 985 billion KRW to enhance its drug delivery platform, focusing on long-acting injectables for obesity and more.

Hemlibra Breakthrough: 91% of Hemophilia Patients in Japan Experience No Adverse Reactions!

JW Pharmaceutical's Hemlibra shows 91% safety in Japanese hemophilia patients, with no adverse reactions in long-term study.

Why Are Weight-Loss Drugs So Much Pricier in South Korea?

South Korea faces high obesity treatment costs compared to China and Japan, with no insurance coverage, despite potential patent expirations.

A New Hair-Growth Pathway?: JW0061 Targets GFRA1 After 7.2x Organoid Results and a 39% Animal Boost

JW Pharmaceutical's hair loss treatment JW0061 gains FDA approval for clinical trials, promising innovative growth stimulation for men and women.

JW Pharmaceutical Advances Gout Treatment with Epaminurad

JW Pharmaceutical advances its gout treatment, Epaminurad, with global trials nearing completion and U.S. patent secured for market entry.

Column-Free Antibody Purification Breakthrough: 97%+ Purity, 4x Faster, and 12x Fewer Impurities

KICET introduces a cost-effective antibody purification system using Tangential Flow Filtration, enhancing efficiency and purity in drug production.

FDA Grants Breakthrough Therapy Designation to Hanmi’s Epheglucagon: What This Means for Rare Disease Treatment

Hanmi Pharmaceutical's efpegerglucagon receives FDA Breakthrough Therapy designation for treating rare Congenital Hyperinsulinism, with Phase 2 results due soon.

Yuhan’s Leclaza and J&J’s Rybrevant: How This Cancer Combo Surged Past 1 Billion USD in Sales

Sales of Yuhan's lung cancer drug 'Lazertinib' and J&J's 'Amivantamab' exceeded 1 trillion won last year.

Korea Clears New Probiotic Claim: hy’s HY7017 Shows Immune Gains in Human Trials

hy's probiotic strain HY7017 has been approved for immune enhancement, adding to its portfolio of nine recognized ingredients.

JW Pharmaceutical Secures U.S. Patent for Hair Loss Drug Candidate JW0061

JW Pharmaceutical secures a U.S. patent for hair loss treatment JW0061, targeting GFRA1 receptor, ensuring market exclusivity until 2039.

Samsung Bioepis Secures U.S. Approval for Pen-Style Stelara Biosimilar, Setting a Market First

Samsung Bioepis receives FDA approval for Epyztek, the first pre-filled pen for autoimmune treatments, enhancing patient convenience.

Patches, Implants, and Oral Films… The Drug-Delivery Format Battle After Oral Wegovy

Oral Wegovy's launch is transforming obesity treatment, focusing on user-friendly delivery methods and enhancing patient adherence.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.